| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
BRIEF REVIEWS |
* Department of Cell Biology and Histology, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands; and
Netherlands Cancer Institute–Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, The Netherlands
The study of development and function of the immune system in vivo has made intensive use of animal models, but performing such work in humans is difficult for experimental, practical, and ethical reasons. Confronted with this scientific challenge, several pioneering groups have developed in the late 1980s mouse models of human immune system development. Although these experimental approaches were proven successful and useful, they were suffering from limitations due to xenograft transplantation barriers. By reviewing the characteristics of the successive models over the last 20 years, it becomes apparent that screening of potentially interesting mouse strains and usage of combinations of genetic deficiencies has led to major advances. This is particularly true for human T cell development in the murine thymus. This review will focus on these advances and the potential future improvements that remain to be accomplished.
This article has been cited by other articles:
|
|
 |
|
  J. Y. Kausman and A. R. Kitching A New Approach to Idiopathic Nephrotic Syndrome J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2621 - 2622. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. An, B. Poon, R. H. T. Fang, K. Weijer, B. Blom, H. Spits, I. S. Y. Chen, and C. H. Uittenbogaart Use of a Novel Chimeric Mouse Model with a Functionally Active Human Immune System To Study Human Immunodeficiency Virus Type 1 Infection Clin. Vaccine Immunol., April 1, 2007; 14(4): 391 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. SHULTZ, T. PEARSON, M. KING, L. GIASSI, L. CARNEY, B. GOTT, B. LYONS, A. A. ROSSINI, and D. L. GREINER Humanized NOD/LtSz-scid IL2 Receptor Common Gamma Chain Knockout Mice in Diabetes Research Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 77 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. KING, T. PEARSON, L. D. SHULTZ, J. LEIF, R. BOTTINO, M. TRUCCO, M. ATKINSON, C. WASSERFALL, K. HEROLD, J. P. MORDES, et al. Development of New-Generation HU-PBMC-NOD/SCID Mice to Study Human Islet Alloreactivity Ann. N.Y. Acad. Sci., April 1, 2007; 1103(1): 90 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gorantla, H. Sneller, L. Walters, J. G. Sharp, S. J. Pirruccello, J. T. West, C. Wood, S. Dewhurst, H. E. Gendelman, and L. Poluektova Human Immunodeficiency Virus Type 1 Pathobiology Studied in Humanized BALB/c-Rag2-/-{gamma}c-/- Mice J. Virol., March 15, 2007; 81(6): 2700 - 2712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Talmadge, R. K. Singh, I. J. Fidler, and A. Raz Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for Cancer Am. J. Pathol., March 1, 2007; 170(3): 793 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. de la Grange, F. Armstrong, V. Duval, M.-C. Rouyez, N. Goardon, P.-H. Romeo, and F. Pflumio Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells Blood, November 1, 2006; 108(9): 2998 - 3004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Baenziger, R. Tussiwand, E. Schlaepfer, L. Mazzucchelli, M. Heikenwalder, M. O. Kurrer, S. Behnke, J. Frey, A. Oxenius, H. Joller, et al. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-{gamma}c-/- mice PNAS, October 24, 2006; 103(43): 15951 - 15956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Legrand, T. Cupedo, A. U. van Lent, M. J. Ebeli, K. Weijer, T. Hanke, and H. Spits Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2-/-{gamma}c-/- mice Blood, July 1, 2006; 108(1): 238 - 245. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
